New York, NY—June 24, 2002
Announcing a $15 million donation from the Starr Foundation, Hospital for Special Surgery launched Discovery to Recovery: The Campaign for Research at its Annual Tribute Dinner, held at the Waldorf=Astoria on Monday, June 24. The dinner, which raised over $1.8 million, honored Maurice R. Greenberg, Chairman & CEO of American International Group, Inc. and the Starr Foundation.
Discovery to Recovery is the largest fundraising initiative in the Hospital’s history. This extraordinary effort has been undertaken to sustain and enhance the Hospital’s research mission of finding new ways to treat, cure, and ultimately prevent musculoskeletal disease.
“With the generous help of our supporters, HSS is on course to change the landscape of orthopedic and rheumatologic science,” said Richard L. Menschel, Chairman of the Board of Trustees. “We are more than halfway towards our goal of $110 million, thanks to the Hospital’s friends, medical staff, and trustees who have contributed over $62 million to the campaign.
John R. Reynolds, President & CEO added, “This tremendous outpouring of support will enable our scientists to achieve breakthroughs at an accelerated pace. It will provide necessary support for HSS to maintain and enhance its reputation as a leader in musculoskeletal medicine and research.”
The launch of Discovery to Recovery: The Campaign for Research could not be more timely considering the increasing amount of attention being paid to musculoskeletal health. The World Health Organization recently declared 2000 to 2010 to be the “Bone and Joint Decade,” in recognition of the serious toll musculoskeletal disorders take on individuals as well as the world’s health care systems and economies. Musculoskeletal injury is the number one reason for doctor visits, accounting for more than 130 million visits per year worldwide. Diseases of the joint account for half of all chronic conditions in people aged 50 and over in developed countries. As the number of people in this age group is expected to double between 1990 and 2020, it has become clear that the need for new discoveries into the causes, cures and treatments of musculoskeletal disease has never been greater.
Crucial to achieving the Hospital’s research objectives is raising philanthropic support for four vital areas of need: recruitment of senior scientists; creation of nearly 72,000 square feet of state-of-the-art research space; advancement of basic and clinical research; and, increasing support to meet the research challenges of the future.
About Hospital for Special Surgery
Hospital for Special Surgery (HSS) is the world’s leading academic medical center focused on musculoskeletal health. HSS is nationally ranked No. 1 in orthopedics and No. 2 in rheumatology by U.S. News & World Report (2016-2017), and is the first hospital in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. HSS has one of the lowest infection rates in the country. HSS is an affiliate of Weill Cornell Medical College and as such all Hospital for Special Surgery medical staff are faculty of Weill Cornell. The hospital's research division is internationally recognized as a leader in the investigation of musculoskeletal and autoimmune diseases. Hospital for Special Surgery is located in New York City and online at www.hss.edu.